Oncologic Interventions: Periprocedural Medications. [Review] (Record no. 100)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02013nam a22003617a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 221213s20222022 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0739-9529 |
| 024 ## - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1055/s-0042-1758079 [doi] |
| 024 ## - OTHER STANDARD IDENTIFIER | |
| Standard number or code | PMC9671681 [pmc] |
| 024 ## - OTHER STANDARD IDENTIFIER | |
| Standard number or code | sir001416 [pii] |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
| PMID | 36406027 |
| 245 ## - TITLE STATEMENT | |
| Title | Oncologic Interventions: Periprocedural Medications. [Review] |
| 251 ## - Source | |
| Source | Seminars in Interventional Radiology. 39(4):406-410, 2022 Aug. |
| 252 ## - Abbreviated Source | |
| Abbreviated source | SEMIN. INTERVENT. RADIOL.. 39(4):406-410, 2022 Aug. |
| 253 ## - Journal Name | |
| Journal name | Seminars in interventional radiology |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Year | 2022 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Manufacturer | FY2023 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Publication date | 2022 Aug |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] | |
| Publication status | epublish |
| 266 ## - Date added to catalog | |
| Date added to catalog | 2022-12-13 |
| 520 ## - SUMMARY, ETC. | |
| Abstract | Significant advances in ablative and endovascular therapies have allowed interventional radiology to play a substantial role in the management of patients with malignant neoplasms. The evolution of these procedures and the optimization of patient outcomes and experience must take into account various elements of the periprocedural period. Some of the most important considerations within the periprocedural period are the pharmacologic agents used to avoid infectious complications, decrease pain, and manage side effects. In this article, we discuss some of the most commonly used medications in interventional oncology procedures including antibiotics, narcotics, sedatives, antiemetics, and others. Copyright Thieme. All rights reserved. |
| 546 ## - LANGUAGE NOTE | |
| Language note | English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | IN PROCESS -- NOT YET INDEXED |
| 656 ## - INDEX TERM--OCCUPATION | |
| Department | MedStar Georgetown University Hospital/MedStar Washington Hospital Center |
| 656 ## - INDEX TERM--OCCUPATION | |
| Department | Radiology/Interventional Integrated Residency |
| 657 ## - INDEX TERM--FUNCTION | |
| Medline publication type | Journal Article |
| 657 ## - INDEX TERM--FUNCTION | |
| Medline publication type | Review |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Local Authors | Boumezrag, Maryam |
| Institution Code | MGUH |
| Program | Radiology/Interventional Integrated Residency |
| Degree | MD |
| Resident year | Resident PGY 4 |
| 790 ## - Authors | |
| All authors | Banovac F, Boumezrag M |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| DOI | <a href="https://dx.doi.org/10.1055/s-0042-1758079">https://dx.doi.org/10.1055/s-0042-1758079</a> |
| Public note | https://dx.doi.org/10.1055/s-0042-1758079 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Journal Article |
| Item type description | Article |
| Withdrawn status | Lost status | Damaged status | Not for loan | Collection | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedStar Authors Catalog | MedStar Authors Catalog | 12/13/2022 | 36406027 | 36406027 | 12/13/2022 | 12/13/2022 | Journal Article |